title: [Long-term-management of organ transplant recipients].
abstract: Due to advances in immunosuppressive therapy and surgical techniques, survival rates after solid organ transplantation have constantly improved over the last decades. In long-term care after transplantation, physicians need to focus as much on diagnosis and treatment of allograft-related complications as they should consider comorbidities and evaluate risk-factors and adverse events of immunosuppressive agents to prevent secondary diseases. In particular, cardiovascular and metabolic diseases, malignancy and infection play a major role in long-term survival. Therefore, screening of organ transplant recipients in regard to these complications and adverse events is a crucial part of follow up in these patients.
authors.forename: Christin
authors.initials: C
authors.lastname: Bürger
authors.forename: Martina
authors.initials: M
authors.lastname: Schmidt
authors.forename: Miriam
authors.initials: M
authors.lastname: Maschmeier
authors.forename: Jaqueline
authors.initials: J
authors.lastname: Stella
authors.forename: Anna
authors.initials: A
authors.lastname: Hüsing
authors.forename: Christian
authors.initials: C
authors.lastname: Wilms
authors.forename: Hartmut Hans-Jürgen
authors.initials: HH
authors.lastname: Schmidt
authors.forename: Iyad
authors.initials: I
authors.lastname: Kabar
mesh_terms: D019317:Evidence-Based Medicine; D005858:Germany; D006084:Graft Rejection / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008134:Long-Term Care / Q000379:methods*; D016377:Organ Transplantation / Q000009:adverse effects* / Q000379:methods*; D016896:Treatment Outcome; D057832:Watchful Waiting / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents